Moderator: Monika Jones
| 12:30 | Welcome address local host Kaspar Sutter, Head of the Department of Economic, Social and Environmental Affairs, Canton of Basel-Stadt |
| 12:35 | Welcome address organizer Michael Altorfer, CEO, Swiss Biotech Association |
| 12:45 | Botnar Institute of Immune Engineering (BIIE) Steven Wilson, CEO |
| 13:00 | Deep Tech Nation Switzerland Foundation Dario My, Head Venture Hub Switzerland |
| 13:15 | Navigating the current environment as a biotechnology company – observations and tactics on capital raising, strategic collaborations and M&A Part I Host: Kenneth Krisko, Partner, Cooley Panelists: Avaleigh Milne, Global Head of Business Development Strategy & Practice, Pharma Partnering, F. Hoffmann-La Roche Tahera Kan, Vice President, Head of Precision Medicine, Johnson & Johnson Luca Santarelli, Founder, Chief Executive Officer, and Chairman of the Board, Windward Bio |
| 13:40 | Part II Host: Patrick Amstutz, CEO, Molecular Partners, & President, Swiss Biotech Association Panelists: Richard Girling, Partner, Centerview Partners Div Gupta, Partner, Cooley David Urech, CEO, Numab Therapeutics |
Plenary session II – Tuesday, May 6, 2025
Host and event manager:
Logistics and marketing partner:
Moderator: Monika Jones
Michael Altorfer, CEO, Swiss Biotech Association
Houman Ashrafian, Executive Vice President, Head of Research and Development, Sanofi
Houman Ashrafian is responsible for bolstering Sanofi’s pipeline of tranformative medicines and vaccines in support of its emergence as a science-driven and innovation leader in industry.
Houman joined Sanofi from SV Health Investors where he was Managing Partner of the global private equity and venture capital investment platform. He co-founded and chaired the biotechs Alchemab Therapeutics, Dualitas, Enara Bio, Mestag Therapeutics, Sitryx and Trex Bio.
Previously, he was Vice President and head of the Clinical Science Group at UCB. Houman is an Honorary Consultant Cardiologist at the John Radcliffe Hospital in Oxford, and a Visiting Professor at the University of Oxford in the U.K.
Moderated by Patrick Amstutz, CEO, Molecular Partners, & President, Swiss Biotech Association
Host: Seth Lewis, Senior Vice President Investor Relations, Communications and Strategy, Molecular Partners
Panelists:
Ivo Staijen, Head of Public Equity, HBM Partners
Karen O’Reilly, Managing Director Healthcare Banking, TD Cowen
Charles Zhu, Managing Director, LifeSci Capital
Lazar Bojic, Vice President, Curie.Bio
Severin Dressen, Director Zurich Zoo
Frederik Schmachtenberg, Partner, Global Life Sciences Lead for Financial Accounting Advisory Services, EY
Jürg Zürcher, jury president